Philip Chambers
University of Leeds(GB)NIHR Leeds Musculoskeletal Biomedical Research Unit(GB)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Epigenetics and DNA Methylation, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Value of Mismatch Repair, KRAS , and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer(2011)675 cited
- → KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial(2009)567 cited
- → Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial(2013)392 cited
- → HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials(2015)234 cited
- → AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K(2009)107 cited
- → Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway